BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19281222)

  • 1. Promiscuous aggregate-based inhibitors promote enzyme unfolding.
    Coan KE; Maltby DA; Burlingame AL; Shoichet BK
    J Med Chem; 2009 Apr; 52(7):2067-75. PubMed ID: 19281222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific mechanism of nonspecific inhibition.
    McGovern SL; Helfand BT; Feng B; Shoichet BK
    J Med Chem; 2003 Sep; 46(20):4265-72. PubMed ID: 13678405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.
    Coan KE; Shoichet BK
    J Am Chem Soc; 2008 Jul; 130(29):9606-12. PubMed ID: 18588298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of detergent on "promiscuous" inhibitors.
    Ryan AJ; Gray NM; Lowe PN; Chung CW
    J Med Chem; 2003 Jul; 46(16):3448-51. PubMed ID: 12877581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting steep dose-response curves in early inhibitor discovery.
    Shoichet BK
    J Med Chem; 2006 Dec; 49(25):7274-7. PubMed ID: 17149857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analyses of AmpC beta-lactamase through differential stability.
    Beadle BM; McGovern SL; Patera A; Shoichet BK
    Protein Sci; 1999 Sep; 8(9):1816-24. PubMed ID: 10493583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition.
    Sulton D; Pagan-Rodriguez D; Zhou X; Liu Y; Hujer AM; Bethel CR; Helfand MS; Thomson JM; Anderson VE; Buynak JD; Ng LM; Bonomo RA
    J Biol Chem; 2005 Oct; 280(42):35528-36. PubMed ID: 15987690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase.
    Tondi D; Powers RA; Caselli E; Negri MC; Blázquez J; Costi MP; Shoichet BK
    Chem Biol; 2001 Jun; 8(6):593-611. PubMed ID: 11410378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on ternary metallo-beta lactamase-inhibitor complexes using electrospray ionization mass spectrometry.
    Selevsek N; Tholey A; Heinzle E; Liénard BM; Oldham NJ; Schofield CJ; Heinz U; Adolph HW; Frère JM
    J Am Soc Mass Spectrom; 2006 Jul; 17(7):1000-4. PubMed ID: 16713713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc ion-induced domain organization in metallo-beta-lactamases: a flexible "zinc arm" for rapid metal ion transfer?
    Selevsek N; Rival S; Tholey A; Heinzle E; Heinz U; Hemmingsen L; Adolph HW
    J Biol Chem; 2009 Jun; 284(24):16419-16431. PubMed ID: 19395380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.
    Reynolds KA; Thomson JM; Corbett KD; Bethel CR; Berger JM; Kirsch JF; Bonomo RA; Handel TM
    J Biol Chem; 2006 Sep; 281(36):26745-53. PubMed ID: 16809340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule aggregates inhibit amyloid polymerization.
    Feng BY; Toyama BH; Wille H; Colby DW; Collins SR; May BC; Prusiner SB; Weissman J; Shoichet BK
    Nat Chem Biol; 2008 Mar; 4(3):197-9. PubMed ID: 18223646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking for fragment inhibitors of AmpC beta-lactamase.
    Teotico DG; Babaoglu K; Rocklin GJ; Ferreira RS; Giannetti AM; Shoichet BK
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7455-60. PubMed ID: 19416920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Stability Effects in Aggregate-Based Enzyme Inhibition.
    Torosyan H; Shoichet BK
    J Med Chem; 2019 Nov; 62(21):9593-9599. PubMed ID: 31589047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture.
    Tondi D; Morandi F; Bonnet R; Costi MP; Shoichet BK
    J Am Chem Soc; 2005 Apr; 127(13):4632-9. PubMed ID: 15796528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A detergent-based assay for the detection of promiscuous inhibitors.
    Feng BY; Shoichet BK
    Nat Protoc; 2006; 1(2):550-3. PubMed ID: 17191086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase inhibitors: not just for kinases anymore.
    McGovern SL; Shoichet BK
    J Med Chem; 2003 Apr; 46(8):1478-83. PubMed ID: 12672248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the AmpC β-lactamase binding site and identification of inhibitors with novel scaffolds.
    Chan FY; Neves MA; Sun N; Tsang MW; Leung YC; Chan TH; Abagyan R; Wong KY
    J Chem Inf Model; 2012 May; 52(5):1367-75. PubMed ID: 22559726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
    Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
    J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Papp-Wallace KM; Taracila M; Hornick JM; Hujer AM; Hujer KM; Distler AM; Endimiani A; Bonomo RA
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2867-77. PubMed ID: 20421396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.